RA Capital Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,000,000
| Closed | -$74M | – | 79 |
|
|
2022
Q3 | $74M | Hold |
2,000,000
| – | – | 1.58% | 18 |
|
|
2022
Q2 | $38M | Hold |
2,000,000
| – | – | 1.01% | 32 |
|
|
2022
Q1 | $54M | Hold |
2,000,000
| – | – | 1.18% | 25 |
|
|
2021
Q4 | $45.1M | Buy |
+2,000,000
| New | +$45.1M | 0.79% | 37 |
|
|
2020
Q4 | – | Sell |
-781,290
| Closed | -$29.4M | – | 86 |
|
|
2020
Q3 | $29.4M | Sell |
781,290
-70,617
| -8% | -$2.66M | 0.54% | 43 |
|
|
2020
Q2 | $38.1M | Sell |
851,907
-528,081
| -38% | -$23.6M | 0.74% | 33 |
|
|
2020
Q1 | $47.1M | Buy |
1,379,988
+618,322
| +81% | +$21.1M | 1.49% | 24 |
|
|
2019
Q4 | $29.7M | Buy |
+761,666
| New | +$29.7M | 0.9% | 24 |
|